Miller Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Miller Wealth Advisors's ABBV Position: Q2 2026 in Review
Miller Wealth Advisors increased its AbbVie (ABBV) stake by 5,643% in Q2 2026, buying an estimated $2.91M and bringing the position to 13,782 shares worth $65.2K. The position accounts for 0.02% of the portfolio, ranked #31.
Miller Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $79K in Q4 2022. 1,724 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Miller Wealth Advisors held 13,782 shares of AbbVie worth $65.2K as of Q2 2026.
- Miller Wealth Advisors bought 13,542 AbbVie shares in Q2 2026, an estimated $2.91M.
- AbbVie made up 0.02% of Miller Wealth Advisors's portfolio in Q2 2026, its #31 holding.
- Miller Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- Miller Wealth Advisors's AbbVie position peaked at $79K in Q4 2022.
- 1,724 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.